Xylem (NYSE:XYL) Price Target Raised to $135.00

Xylem (NYSE:XYL) had its price target lifted by TD Cowen from $130.00 to $135.00 in a report released on Friday,Benzinga reports. The brokerage presently has a “hold” rating on the industrial products company’s stock. TD Cowen’s price objective suggests a potential downside of 3.01% from the stock’s current price.

Other research analysts have also issued research reports about the stock. UBS Group increased their price target on shares of Xylem from $168.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, November 6th. Citigroup raised their target price on Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Zacks Research cut Xylem from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Weiss Ratings reissued a “buy (b)” rating on shares of Xylem in a report on Monday. Finally, Barclays boosted their target price on shares of Xylem from $165.00 to $172.00 and gave the company an “overweight” rating in a research note on Wednesday, October 29th. Eight equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, Xylem presently has an average rating of “Moderate Buy” and an average target price of $167.40.

Xylem Stock Performance

XYL stock traded down $1.68 during midday trading on Friday, hitting $139.20. The stock had a trading volume of 398,062 shares, compared to its average volume of 1,403,830. Xylem has a 52 week low of $100.47 and a 52 week high of $154.27. The company has a current ratio of 1.96, a quick ratio of 1.50 and a debt-to-equity ratio of 0.17. The stock has a 50-day simple moving average of $145.94 and a 200 day simple moving average of $138.43. The firm has a market capitalization of $33.89 billion, a price-to-earnings ratio of 35.78, a P/E/G ratio of 2.19 and a beta of 1.18.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.23 by $0.14. The firm had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.22 billion. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The business’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.11 EPS. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. As a group, equities research analysts anticipate that Xylem will post 4.65 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Victoria D. Harker sold 1,700 shares of the company’s stock in a transaction on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the transaction, the director owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This represents a 9.15% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction dated Thursday, October 30th. The shares were sold at an average price of $152.64, for a total value of $1,590,661.44. Following the completion of the transaction, the executive vice president owned 31,250 shares in the company, valued at approximately $4,770,000. This represents a 25.01% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.27% of the company’s stock.

Institutional Investors Weigh In On Xylem

Institutional investors and hedge funds have recently modified their holdings of the business. Avantax Advisory Services Inc. raised its position in shares of Xylem by 28.7% during the 1st quarter. Avantax Advisory Services Inc. now owns 3,049 shares of the industrial products company’s stock valued at $364,000 after acquiring an additional 680 shares during the last quarter. XTX Topco Ltd acquired a new stake in shares of Xylem during the first quarter worth $321,000. Atria Wealth Solutions Inc. bought a new stake in Xylem in the first quarter valued at about $886,000. Vanguard Group Inc. lifted its stake in Xylem by 1.3% in the first quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company’s stock valued at $3,465,122,000 after buying an additional 362,127 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Xylem by 2.2% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,418,719 shares of the industrial products company’s stock worth $169,480,000 after buying an additional 30,608 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.